Drug
Rbd1119
Rbd1119: highest development phase Phase 1, developed by Suzhou Ribo Life Science Co. Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Suzhou Ribo Life Science Co. Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| RBD1119 NCT07042594 | Phase 1 |
Latest
No recent events.
Follow Rbd1119 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.